Angioimmunoblastic T‐cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta‐analysis of 56 cases
- 17 January 2012
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 60 (4), 570-585
- https://doi.org/10.1111/j.1365-2559.2011.04097.x
Abstract
Tan L H C, Tan S Y, Tang T, Lim S T, Tan D, Lim L C, Kam G L S, Loh T P, Tao M & Koay E S C (2012) Histopathology 60, 570–585 Angioimmunoblastic T‐cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta‐analysis of 56 cases Aims: Angioimmunoblastic T‐cell lymphoma (AITL) may present in patterns 1, 2 or 3, representing those with hyperplastic, regressed or effaced germinal centres (GCs), respectively, but the prognostic utility of this subclassification has not been previously validated. Methods and results: Twenty‐five cases of AITL were reviewed immunohistologically and with in‐situ hybridization for Epstein–Barr virus‐encoded RNA and polymerase chain reaction for T‐cell receptor gamma and immunoglobulin heavy chain clonality and followed for up to 120 months. Four cases had conventional hyperplastic GCs, two had floral GCs, and one had progressively transformed GCs, consistent with pattern 1 and one additional case had hyalinized GCs, consistent with pattern 2. The remaining 17 (pattern 3) cases lacked morphologically discernible GCs. The Kaplan–Meier survival distribution of pattern 1 cases (5‐year survival 83%) was superior to that of pattern 2 and 3 cases [5‐year‐survival 36% (P = 0.0417)] only when combined with the 31 cases, seven of which were pattern 1, that Attygalle et al. had followed for up to 247 months and previously published. Furthermore, the development of B‐lineage (classical Hodgkin or diffuse large‐cell) lymphoma was associated exclusively with pattern 3 (P = 0.0057). Conclusions: Pattern 1 represents an indolent phase/grade of AITL, unassociated with the development of secondary B‐lineage lymphoma and uninfluenced by treatment regimen.Keywords
This publication has 37 references indexed in Scilit:
- B and T Lymphocyte Attenuator Suppresses IL-21 Production from Follicular Th Cells and Subsequent Humoral Immune ResponsesPublished by The American Association of Immunologists ,2010
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaBlood, 2010
- Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell LymphomasThe American Journal of Surgical Pathology, 2009
- Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expressionBlood, 2008
- Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2008
- Morphologic and Immunophenotypic Variants of Nodal T-Cell Lymphomas and T-Cell Lymphoma MimicsAmerican Journal of Clinical Pathology, 2007
- Distinguishing angioimmunoblastic T‐cell lymphoma from peripheral T‐cell lymphoma, unspecified, using morphology, immunophenotype and molecular geneticsHistopathology, 2007
- The Ets factor Spi-B is a direct critical target of the coactivator OBF-1Proceedings of the National Academy of Sciences of the United States of America, 2006
- Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein–Barr virus infection. A different subtype of AILD-TL?Leukemia, 2002
- Germinal Center Founder Cells Display Propensity for Apoptosis before Onset of Somatic MutationThe Journal of Experimental Medicine, 1997